Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

VEGF targeted therapy and chemo an active combination in rapidly progressive...

Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA

VEGF targeted therapy and chemo an active combination in rapidly progressive renal cell carcinoma ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )

Impact of statins on survival outcomes in metastatic renal cell carcinoma

Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA

Impact of statins on survival outcomes in metastatic renal cell carcinoma ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )

Genomic profiling may reveal new drug targets in urothelial carcinoma

Dr Jeffrey Ross - Albany Medical College, Albany, USA

Genomic profiling may reveal new drug targets in urothelial carcinoma ( Dr Jeffrey Ross - Albany Medical College, Albany, USA )

Combination of abiraterone and cabazitaxel in metastatic castration-resistant...

Dr Joaquin Mateo - Institute of Cancer Research, London, UK

Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer ( Dr Joaquin Mateo - Institute of Cancer Research, London, UK )

Management after radical prostatectomy: early adjuvant radiotherapy or wait-and...

Dr Mohammad Parvez Shaikh - Loyola University Medical Centre, Maywood, USA

Management after radical prostatectomy: early adjuvant radiotherapy or wait-and-see? ( Dr Mohammad Parvez Shaikh - Loyola University Medical Centre, Maywood, USA )

Is there a role for androgen deprivation therapy combined with radiotherapy in...

Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada

Is there a role for androgen deprivation therapy combined with radiotherapy in intermediate risk prostate cancer? ( Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada )

When and whether to conduct endocrine therapy in non-metastatic prostate cancer

Dr Frederik Birkebæk Thomsen - University of Copenhagen, Copenhagen, Denmark

When and whether to conduct endocrine therapy in non-metastatic prostate cancer ( Dr Frederik Birkebæk Thomsen - University of Copenhagen, Copenhagen, Denmark )

High BMI beneficial in kidney cancer

Dr Laurence Albiges - Dana-Farber Cancer Institute, Boston, USA

High BMI beneficial in kidney cancer ( Dr Laurence Albiges - Dana-Farber Cancer Institute, Boston, USA )

Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial...

Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA

Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer ( Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA )

New approach to prostate cancer screening

Dr Sanoj Punnen - University of Miami, Miami, USA

New approach to prostate cancer screening ( Dr Sanoj Punnen - University of Miami, Miami, USA )

ASCO GU 2015: Review of the latest data in prostate cancer

Prof Eleni Efstathiou, Prof Charles Ryan, Dr Heather Payne

ASCO GU 2015: Review of the latest data in prostate cancer ( Prof Eleni Efstathiou, Prof Charles Ryan, Dr Heather Payne )

Dose-escalated brachytherapy best treatment for unfavourable-risk localised...

Dr Scott Tyldesley - British Columbia Cancer Agency, Vancouver, Canada

Dose-escalated brachytherapy best treatment for unfavourable-risk localised prostate cancer ( Dr Scott Tyldesley - British Columbia Cancer Agency, Vancouver, Canada )

More from ecancer